Men's Health News

Voluntary medical male circumcision can reduce the risk for HIV acquisition among men who have sex with men who primarily practice insertive anal sex, according to the results of a randomized controlled trial conducted in China.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the role of hormone blocking therapies in prostate cancer care.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the role of hormone blocking therapies in prostate cancer care.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses disparities in care that exist in the treatment of prostate cancer.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses risk factors for prostate cancer.

In these videos, Tanya Dorff, MD, professor in the  Department of Medical Oncology & Therapeutics Research and serves as section chief of the Genitourinary Disease Program at City of Hope discusses the latest developments in prostate cancer treatment.

In the TRAVERSE trial, men with hypogonadism at high risk for CVD who received testosterone had a similar risk for major adverse cardiovascular events compared with those who received placebo.

In recognition of National Men’s Health Week, the Society of Interventional Radiology hosted a congressional press briefing on prostate artery embolization, a procedure used to treat benign prostatic hyperplasia.

The FDA has granted over-the-counter authorization to Futura Medical for its topically applied gel treatment for erectile dysfunction as a de novo medical device, the company announced in a press release.

A network-based model demonstrated that men who have sex with men drive the Neisseria gonorrhoeae epidemic and that intensive screening in the low-risk population had little impact on decreasing transmission rates.